(Q44247877)

1 December 2017

title

Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Wasif A Khan

1

1 reference

1 December 2017

Debasish Saha

2

1 reference

1 December 2017

Anisur Rahman

3

1 reference

1 December 2017

Mohammed A Salam

4

1 reference

1 December 2017

Joseph Bogaerts

5

1 reference

1 December 2017

Michael L Bennish

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

360

1 reference

1 December 2017

issue

9347

1 reference

1 December 2017

page(s)

1722-1727

1 reference

TETRACYCLINE IN THE TREATMENT OF CHOLERA

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Single-dose doxycycline for cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Single dose tetracycline in cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Randomised double blind trial of single dose doxycycline for treating cholera in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Efficacy of a single dose of furazolidone for treatment of cholera in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Paediatric safety of azithromycin: worldwide experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Randomised controlled trial of single-dose azithromycin in treatment of trachoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

1 reference

7 January 2021

Pediatric study of medicines becomes mandatory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911680-1

7 January 2021

10.1016/S0140-6736(02)11680-1

Identifiers

DOI

1 reference

1 December 2017

1 reference